We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prognosis Association of Hypocalcemia on Moderate-severe TBI, COHORTE STUDY

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01236911
Recruitment Status : Unknown
Verified November 2010 by Universidad Autonoma de San Luis Potosí.
Recruitment status was:  Recruiting
First Posted : November 9, 2010
Last Update Posted : November 9, 2010
Sponsor:
Information provided by:
Universidad Autonoma de San Luis Potosí

Brief Summary:
Will have bad prognosis the patients with low calcium (less of 24 hrs of te admission in hospital)after moderate - severe TBI that the patients that do not developed this condition?

Condition or disease Intervention/treatment
Calcium , Prognosis in Patients Other: Calcium Measurement

Detailed Description:
Through the years the investigators have seen that the patients with low calcium after moderate-severe TBI had bad prognosis including more complications, and more days in hospital. The investigators want to make an association between the patients that developed this condition and the patients that do not developed this condition

Study Type : Observational
Estimated Enrollment : 20 participants
Observational Model: Cohort
Time Perspective: Prospective
Study Start Date : October 2010
Estimated Primary Completion Date : September 2012
Estimated Study Completion Date : November 2012

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Calcium
U.S. FDA Resources

Group/Cohort Intervention/treatment
Calcium after moderate-severe TBI
Patients with moderate -severe TBI with less as 24 hrs , admitted in emergency. We will measure seric calcium to compare the differences between both groups
Other: Calcium Measurement
after moderate-severe TBI (less as 24 hrs)



Primary Outcome Measures :
  1. Establishment an association between the patients that developed Hypocalcemia less 24 hrs after moderate-severe TBI with patients that did not develop this condition [ Time Frame: 2 years ]

Secondary Outcome Measures :
  1. Identify the more relevant prognosis factors [ Time Frame: 2 years ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   16 Years to 65 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients bettween 16 and 65 years old with moderate -severe TBI with less as 24 hours , without administration of steroids or statins
Criteria

Inclusion Criteria:

  • Man - woman between 16-65 years old with moderate -severe TBI less as 24 hrs,Count with tomographic study

Exclusion Criteria:

  • Use of steroids, use of statins, Administration of Tromethamine, calcium antagonists, fibrates, niacin, cyclosporine, macrolides.
  • Unclassifiable lesions in brainstem

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01236911


Contacts
Contact: Juan manuel Viñas, M.D. 0052 44 48 262344 ext 519 weinweg21@hotmail.com

Locations
Mexico
Juan Manuel Viñas Rios Recruiting
San Luis Potosi, Mexico, 78210
Contact: Juan Manuel Viñas, M.D.    0052 44 48 26 23 44 ext 519    weinweg21@hotmail.com   
Sponsors and Collaborators
Universidad Autonoma de San Luis Potosí

Responsible Party: Juan Manuel Viñas Rios, UASLP fACULTY OF MEDICINE
ClinicalTrials.gov Identifier: NCT01236911     History of Changes
Other Study ID Numbers: NCT071110
First Posted: November 9, 2010    Key Record Dates
Last Update Posted: November 9, 2010
Last Verified: November 2010

Keywords provided by Universidad Autonoma de San Luis Potosí:
Calcium , TBI,complications, days in hospital

Additional relevant MeSH terms:
Calcium, Dietary
Bone Density Conservation Agents
Physiological Effects of Drugs